![](/img/cover-not-exists.png)
Third-Line Sorafenib After Sequential Therapy With Sunitinib and mTOR Inhibitors in Metastatic Renal Cell Carcinoma
Giuseppe Di Lorenzo, Carlo Buonerba, Piera Federico, Pasquale Rescigno, Michele Milella, Cinzia Ortega, Michele Aieta, Carmine D’Aniello, Nicola Longo, Alessandra Felici, Enzo Maria Ruggeri, GiovannelVolume:
58
Year:
2010
Language:
english
Pages:
6
DOI:
10.1016/j.eururo.2010.09.008
File:
PDF, 242 KB
english, 2010